CRP and Hypoalbuminemia: There is increasing evidence that systemic inflammatory response is a key determinant of outcome in patients with cancer, which is reflected by many biochemical or hematological parameters, such as increased C-reactive protein (CRP) levels, hypoalbuminemia or elevated white cell, neutrophil and platelet counts [4].